16-67436149-G-GC
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000196.4(HSD11B2):c.664+16dupC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00139 in 1,564,162 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0010 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0014 ( 3 hom. )
Consequence
HSD11B2
NM_000196.4 intron
NM_000196.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.349
Publications
0 publications found
Genes affected
HSD11B2 (HGNC:5209): (hydroxysteroid 11-beta dehydrogenase 2) There are at least two isozymes of the corticosteroid 11-beta-dehydrogenase, a microsomal enzyme complex responsible for the interconversion of cortisol and cortisone. The type I isozyme has both 11-beta-dehydrogenase (cortisol to cortisone) and 11-oxoreductase (cortisone to cortisol) activities. The type II isozyme, encoded by this gene, has only 11-beta-dehydrogenase activity. In aldosterone-selective epithelial tissues such as the kidney, the type II isozyme catalyzes the glucocorticoid cortisol to the inactive metabolite cortisone, thus preventing illicit activation of the mineralocorticoid receptor. In tissues that do not express the mineralocorticoid receptor, such as the placenta and testis, it protects cells from the growth-inhibiting and/or pro-apoptotic effects of cortisol, particularly during embryonic development. Mutations in this gene cause the syndrome of apparent mineralocorticoid excess and hypertension. [provided by RefSeq, Feb 2010]
HSD11B2 Gene-Disease associations (from GenCC):
- apparent mineralocorticoid excessInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 16-67436149-G-GC is Benign according to our data. Variant chr16-67436149-G-GC is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 723515.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.001 (151/150936) while in subpopulation EAS AF = 0.00293 (15/5118). AF 95% confidence interval is 0.00181. There are 0 homozygotes in GnomAd4. There are 78 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HSD11B2 | ENST00000326152.6 | c.664+7_664+8insC | splice_region_variant, intron_variant | Intron 3 of 4 | 1 | NM_000196.4 | ENSP00000316786.5 | |||
| HSD11B2 | ENST00000567684.2 | n.527+7_527+8insC | splice_region_variant, intron_variant | Intron 3 of 3 | 3 | |||||
| HSD11B2 | ENST00000566606.1 | n.*472_*473insC | downstream_gene_variant | 5 | ENSP00000473429.1 |
Frequencies
GnomAD3 genomes AF: 0.000995 AC: 150AN: 150828Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
150
AN:
150828
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00340 AC: 715AN: 210458 AF XY: 0.00197 show subpopulations
GnomAD2 exomes
AF:
AC:
715
AN:
210458
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00143 AC: 2024AN: 1413226Hom.: 3 Cov.: 36 AF XY: 0.00142 AC XY: 999AN XY: 703968 show subpopulations
GnomAD4 exome
AF:
AC:
2024
AN:
1413226
Hom.:
Cov.:
36
AF XY:
AC XY:
999
AN XY:
703968
show subpopulations
African (AFR)
AF:
AC:
61
AN:
32438
American (AMR)
AF:
AC:
43
AN:
43838
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
25370
East Asian (EAS)
AF:
AC:
134
AN:
38324
South Asian (SAS)
AF:
AC:
101
AN:
84868
European-Finnish (FIN)
AF:
AC:
376
AN:
50646
Middle Eastern (MID)
AF:
AC:
6
AN:
5536
European-Non Finnish (NFE)
AF:
AC:
1231
AN:
1073960
Other (OTH)
AF:
AC:
70
AN:
58246
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.402
Heterozygous variant carriers
0
109
217
326
434
543
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00100 AC: 151AN: 150936Hom.: 0 Cov.: 31 AF XY: 0.00106 AC XY: 78AN XY: 73722 show subpopulations
GnomAD4 genome
AF:
AC:
151
AN:
150936
Hom.:
Cov.:
31
AF XY:
AC XY:
78
AN XY:
73722
show subpopulations
African (AFR)
AF:
AC:
44
AN:
41212
American (AMR)
AF:
AC:
3
AN:
15148
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3436
East Asian (EAS)
AF:
AC:
15
AN:
5118
South Asian (SAS)
AF:
AC:
6
AN:
4770
European-Finnish (FIN)
AF:
AC:
0
AN:
10390
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
82
AN:
67586
Other (OTH)
AF:
AC:
1
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Apparent mineralocorticoid excess Benign:1
Sep 28, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.